These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10429982)

  • 1. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis.
    Borg N; Götharson E; Benfeldt E; Groth L; Ståhle L
    Acta Derm Venereol; 1999 Jul; 79(4):274-7. PubMed ID: 10429982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.
    Pue MA; Pratt SK; Fairless AJ; Fowles S; Laroche J; Georgiou P; Prince W
    J Antimicrob Chemother; 1994 Jan; 33(1):119-27. PubMed ID: 8157552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of penciclovir in healthy cats following oral administration of famciclovir or intravenous infusion of penciclovir.
    Thomasy SM; Whittem T; Bales JL; Ferrone M; Stanley SD; Maggs DJ
    Am J Vet Res; 2012 Jul; 73(7):1092-9. PubMed ID: 22738064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of penciclovir following oral administration of famciclovir to cats.
    Thomasy SM; Maggs DJ; Moulin NK; Stanley SD
    Am J Vet Res; 2007 Nov; 68(11):1252-8. PubMed ID: 17975982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of penciclovir after oral administration of its prodrug famciclovir to horses.
    Tsujimura K; Yamada M; Nagata S; Yamanaka T; Nemoto M; Kondo T; Kurosawa M; Matsumura T
    J Vet Med Sci; 2010 Mar; 72(3):357-61. PubMed ID: 19959884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of famciclovir and penciclovir in tears following oral administration of famciclovir to cats: a pilot study.
    Thomasy SM; Covert JC; Stanley SD; Maggs DJ
    Vet Ophthalmol; 2012 Sep; 15(5):299-306. PubMed ID: 22339892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir].
    Vere Hodge RA; Sutton D; Boyd MR; Harnden MR; Jarvest RL
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1765-73. PubMed ID: 2589844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous penetration of orally administered famciclovir.
    Chong DY; Johnson MW; Huynh TH; Hall EF; Comer GM; Fish DN
    Am J Ophthalmol; 2009 Jul; 148(1):38-42.e1. PubMed ID: 19375688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modeling of penciclovir and BRL42359 in the plasma and tears of healthy cats to optimize dosage recommendations for oral administration of famciclovir.
    Sebbag L; Thomasy SM; Woodward AP; Knych HK; Maggs DJ
    Am J Vet Res; 2016 Aug; 77(8):833-45. PubMed ID: 27463546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical pharmacokinetics of famciclovir.
    Gill KS; Wood MJ
    Clin Pharmacokinet; 1996 Jul; 31(1):1-8. PubMed ID: 8827396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.
    Boike SC; Pue M; Audet PR; Freed MI; Fairless A; Ilson BE; Zariffa N; Jorkasky DK
    J Clin Pharmacol; 1994 Dec; 34(12):1199-207. PubMed ID: 7738216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of the pharmacokinetics of famciclovir and its active metabolite penciclovir in young Asian elephants (Elephas maximus).
    Brock AP; Isaza R; Hunter RP; Richman LK; Montali RJ; Schmitt DL; Koch DE; Lindsay WA
    Am J Vet Res; 2012 Dec; 73(12):1996-2000. PubMed ID: 23176429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological profile of famciclovir.
    Crumpacker C
    Semin Dermatol; 1996 Jun; 15(2 Suppl 1):14-26. PubMed ID: 8840412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and pharmacokinetic studies following oral administration of famciclovir to the rat and dog.
    Filer CW; Ramji JV; Allen GD; Brown TA; Fowles SE; Hollis FJ; Mort EE
    Xenobiotica; 1995 May; 25(5):477-90. PubMed ID: 7571721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of isotopically chiral [4'-13C]famciclovir and 13C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract.
    Vere Hodge RA; Darlison SJ; Readshaw SA
    Chirality; 1993; 5(8):577-82. PubMed ID: 8305284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis.
    Morgan CJ; Renwick AG; Friedmann PS
    Br J Dermatol; 2003 Mar; 148(3):434-43. PubMed ID: 12653734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent clinical experience with famciclovir--a "third generation" nucleoside prodrug.
    Chakrabarty A; Tyring SK; Beutner K; Rauser M
    Antivir Chem Chemother; 2004 Sep; 15(5):251-3. PubMed ID: 15535046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model.
    Schenkel F; Csajka C; Baglivo E; Kondo-Oestreicher M; Dayer P; Gex-Fabry M; Daali Y
    J Antimicrob Chemother; 2013 Jul; 68(7):1635-41. PubMed ID: 23539240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famciclovir for treatment of herpesvirus infections.
    Luber AD; Flaherty JF
    Ann Pharmacother; 1996 Sep; 30(9):978-85. PubMed ID: 8876860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.